Search Within

Katherine S Panageas

Formats
  1. Journal Article (316)
  2. Meeting Abstract (181)
  3. Editorial (5)
  4. Research Letter (5)
  5. Correspondence (4)
  6. Review (4)
  7. Book Section (3)
  8. Miscellaneous (1)
Groups
  1. Biostatistics Service (519)
  2. Epidemiology and Biostatistics (519)
  3. Population Sciences Research Program (519)
  4. Department of Medicine (305)
  5. Solid Tumor Oncology Division (263)
  6. GSK Faculty (188)

More Groups

People
  1. Anne Reiner (92)
  2. Jedd Wolchok (92)
  3. Lisa De Angelis (85)
  4. Paul Chapman (77)
  5. Michael Postow (66)
  6. Clifford Hudis (56)

More People

Years
  1. 2025 (15)
  2. 2024 (23)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (34)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (109)
  2. Neuro-Oncology (40)
  3. Clinical Cancer Research (31)
  4. Annals of Surgical Oncology (28)
  5. Cancer (21)
  6. Breast Cancer Research and Treatment (20)

More Publications

Publishers
  1. American Society of Clinical Oncology (122)
  2. Oxford University Press (65)
  3. Springer (65)
  4. American Association for Cancer Research (56)
  5. Wiley Blackwell (38)
  6. American Medical Association (19)

More Publishers

Results (519)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Uncertainty around individualized predictions using nomograms: The concept of individualized prediction intervals
    Meeting Abstract

    Iasonos, A.; Schrag, D.; Raj, G. V.; Russo, P.; Panageas, K. S.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Adjuvant (adj) bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-p) in early stage breast cancer (BC) patients (pts): Cardiac safety
    Meeting Abstract

    Dickler, M. N.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Sugarman, S.; Norton, L.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • What is the role of whole brain radiation therapy (WBRT) and high-dose cytarabine (Ara-C) as consolidation treatment after initial chemotherapy for primary CNS lymphoma (PCNSL)?
    Meeting Abstract

    Ekenel, M.; Iwamoto, F. M.; Ben Porat, L. S.; Panageas, K. S.; Yahalom, J.; DeAngelis, L. M.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Treatment patterns and prognosis in patients with human immunodeficiency virus (HIV) and primary central nervous system lymphoma (PCNSL)
    Meeting Abstract

    Nguyen, T.; Panageas, K.; Elkin, E.; DeAngelis, L.; Abrey, L.
    Neuro-Oncology (2007)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab plus dose-dense doxorubicin/cyclophosphamide followed by nanoparticle albumin-bound paclitaxel in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H. L.; Rugo, H.; Paulson, M.; Rourke, M.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Park, J.; more...
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save
  • Clinical and molecular-metabolic phase II trial of perifosine for recurrent/progressive malignant glioma
    Meeting Abstract

    Lassman, A.; Holland, E.; DeAngelis, L.; Panageas, K.; Abrey, L.
    Neuro-Oncology (2007)

    Fulltext@MSK | Save
  • A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose-dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
    Meeting Abstract

    Clarke, J.; Sul, J.; DeAngelis, L.; Lassman, A.; Hormigo, A.; Nolan, C.; Gavrilovic, I.; Gu, B.; Panageas, K.; Abrey, L.
    Neuro-Oncology (2007)

    Fulltext@MSK | Save
  • Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma
    Journal Article

    Wolchok, J. D.; Yuan, J.; Houghton, A. N.; Gallardo, H. F.; Rasalan, T. S.; Wang, J.; Zhang, Y.; Ranganathan, R.; Chapman, P. B.; Krown, S. E.; more...
    Molecular Therapy (2007)

    Fulltext@MSK | Save
  • Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma
    Journal Article

    Taylor, R. C.; Patel, A.; Panageas, K. S.; Busam, K. J.; Brady, M. S.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size
    Journal Article

    Panageas, K. S.; Schrag, D.; Localio, A. R.; Venkatraman, E. S.; Begg, C. B.
    Statistics in Medicine (2007)

    Fulltext@MSK | Save